Miniature Swine As a Clinically Relevant Model of Graft-Versus-Host Disease

Overview

Journal Comp Med

Specialty General Medicine

Date 2015 Oct 17

PMID 26473348

Citations 9

Authors

Raimon Duran-Struuck

Christene A Huang

Katherine Orf

Roderick T Bronson

David H Sachs

Thomas R Spitzer

Affiliations

Soon will be listed here.

Abstract

Miniature swine provide a preclinical model of hematopoietic cell transplantation (HCT) for studies of graft-versus-host disease. HCT between MHC-matched or -mismatched pigs can be performed to mimic clinical scenarios with outcomes that closely resemble those observed in human HCT recipients. With myeloablative conditioning, HCT across MHC barriers is typically fatal, with pigs developing severe (grade III or IV) GVHD involving the gastrointestinal tract, liver, and skin. Unlike rodent models, miniature swine provide an opportunity to perform extended longitudinal studies on individual animals, because multiple tissue biopsies can be harvested without the need for euthanasia. In addition, we have developed a swine GVHD scoring system that parallels that used in the human clinical setting. Given the similarities of GVHD in pigs and humans, we hope that the use of this scoring system facilitates clinical and scientific discourse between the laboratory and the clinic. We anticipate that results of swine studies will support the development of new strategies to improve the identification and treatment of GVHD in clinical HCT scenarios.

Citing Articles

Fetal bone engraftment reconstitutes the immune system in pigs with severe combined immunodeficiency.

Monarch K, Yoon J, Uh K, Reese E, Restrepo D, de Carvalho Madrid D Lab Anim (NY). 2024; 53(10):276-286.

PMID: 39289566 PMC: 11439731. DOI: 10.1038/s41684-024-01439-7.

Harnessing diversity and antagonism within the pig skin microbiota to identify novel mediators of colonization resistance to methicillin-resistant .

Wei M, Flowers L, Knight S, Zheng Q, Murga-Garrido S, Uberoi A mSphere. 2023; 8(4):e0017723.

PMID: 37404023 PMC: 10449522. DOI: 10.1128/msphere.00177-23.

Species origin of exogenous transcription factors affects the activation of endogenous pluripotency markers and signaling pathways of porcine induced pluripotent stem cells.

Zhou M, Zhang M, Guo T, Zhao L, Guo X, Yin Z Front Cell Dev Biol. 2023; 11:1196273.

PMID: 37152293 PMC: 10160484. DOI: 10.3389/fcell.2023.1196273.

Genetic Association between Farrowing Rates and Swine Leukocyte Antigen Alleles or Haplotypes in Microminipigs.

Ando A, Matsubara T, Suzuki S, Imaeda N, Takasu M, Shigenari A Cells. 2022; 11(19).

PMID: 36231100 PMC: 9563624. DOI: 10.3390/cells11193138.

Epstein-Barr Virus-Encoded BILF1 Orthologues From Porcine Lymphotropic Herpesviruses Display Common Molecular Functionality.

Mavri M, Kubale V, Depledge D, Zuo J, Huang C, Breuer J Front Endocrinol (Lausanne). 2022; 13:862940.

PMID: 35721730 PMC: 9204316. DOI: 10.3389/fendo.2022.862940.

References

Saalmuller A, Aasted B, Canals A, Dominguez J, Goldman T, Lunney J . Analyses of monoclonal antibodies reactive with porcine CD6. Vet Immunol Immunopathol. 1994; 43(1-3):243-7. DOI: 10.1016/0165-2427(94)90143-0. View

Wang Z, Duran-Struuck R, Crepeau R, Matar A, Hanekamp I, Srinivasan S . Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin. Bioconjug Chem. 2011; 22(10):2014-20. PMC: 3200572. DOI: 10.1021/bc200230h. View

Swindle M, Makin A, Herron A, Clubb Jr F, Frazier K . Swine as models in biomedical research and toxicology testing. Vet Pathol. 2011; 49(2):344-56. DOI: 10.1177/0300985811402846. View

Wu P, Cowen E . Cutaneous graft-versus-host disease--clinical considerations and management. Curr Probl Dermatol. 2012; 43:101-15. PMC: 7458413. DOI: 10.1159/000335270. View

Matar A, Crepeau R, Pathiraja V, Robson S, Fishman J, Spitzer T . Effects of mobilization regimens in donors on outcomes of hematopoietic cell transplantation in miniature Swine. Comp Med. 2013; 62(6):487-94. PMC: 3527753. View

Ferrara J, Levy R, Chao N . Pathophysiologic mechanisms of acute graft-vs.-host disease. Biol Blood Marrow Transplant. 1999; 5(6):347-56. DOI: 10.1016/s1083-8791(99)70011-x. View

Huang C, Fuchimoto Y, Murphy M, Neville Jr D, Sachs D . Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model. J Clin Invest. 2000; 105(2):173-81. PMC: 377429. DOI: 10.1172/JCI7913. View

Fuchimoto Y, Huang C, Yamada K, Shimizu A, Kitamura H, Colvin R . Mixed chimerism and tolerance without whole body irradiation in a large animal model. J Clin Invest. 2000; 105(12):1779-89. PMC: 378506. DOI: 10.1172/JCI8721. View

Ramirez P, Chavez R, Majado M, Munitiz V, Munoz A, Hernandez Q . Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation. 2000; 70(7):989-98. DOI: 10.1097/00007890-200010150-00001. View

10.

Platt J . Physiologic barriers to xenotransplantation. Transplant Proc. 2000; 32(7):1547-8. DOI: 10.1016/s0041-1345(00)01342-7. View

11.

Haverson K, Saalmuller A, Alvarez B, Alonso F, Bailey M, Bianchi A . Overview of the Third International Workshop on Swine Leukocyte Differentiation Antigens. Vet Immunol Immunopathol. 2001; 80(1-2):5-23. DOI: 10.1016/s0165-2427(01)00290-2. View

12.

Haverson K, Saalmuller A, Chen Z, Huang C, Simon A, Seebach J . Summary of the first round analyses of the Third International Workshop on Swine Leukocyte Differentiation Antigens. Vet Immunol Immunopathol. 2001; 80(1-2):25-34. DOI: 10.1016/s0165-2427(01)00291-4. View

13.

Sinkora J, Rehakova Z, Haverson K, Sinkora M, Dominguez J, Huang C . Monoclonal antibodies putatively recognising activation and differentiation antigens. Vet Immunol Immunopathol. 2001; 80(1-2):143-64. DOI: 10.1016/s0165-2427(01)00283-5. View

14.

Haverson K, Bailey M, Stokes C, Simon A, LeFlufy L, Banfield G . Monoclonal antibodies raised to human cells--specificity for pig leukocytes. Vet Immunol Immunopathol. 2001; 80(1-2):175-86. DOI: 10.1016/s0165-2427(01)00285-9. View

15.

Kunisaki S, Haller G, Fuchimoto Y, Huang C, Sachs D . Peripheral regulation of graft-versus-host alloreactivity in mixed chimeric miniature swine. Transplantation. 2001; 72(3):523-6. DOI: 10.1097/00007890-200108150-00027. View

16.

Teshima T, Ferrara J . Understanding the alloresponse: new approaches to graft-versus-host disease prevention. Semin Hematol. 2002; 39(1):15-22. DOI: 10.1053/shem.2002.29246. View

17.

Lauritsen T, Grunnet N, Rasmussen A, Secher N, Quistorff B . The effect of hepatectomy on glucose homeostasis in pig and in man. J Hepatol. 2002; 36(1):99-104. DOI: 10.1016/s0168-8278(01)00241-0. View

18.

Hunter K, Williams R . Complexities of cancer research: mouse genetic models. ILAR J. 2002; 43(2):80-8. DOI: 10.1093/ilar.43.2.80. View

19.

Cohen J, Trenado A, Vasey D, Klatzmann D, Salomon B . CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J Exp Med. 2002; 196(3):401-6. PMC: 2193933. DOI: 10.1084/jem.20020090. View

20.

Copelan E, Kapoor N, Berliner M, Tutschka P . Bone marrow transplantation without total-body irradiation in patients aged 40 and older. Transplantation. 1989; 48(1):65-8. DOI: 10.1097/00007890-198907000-00015. View